tiprankstipranks
Trending News
More News >
Medical Net,Inc. (JP:3645)
:3645
Japanese Market

Medical Net,Inc. (3645) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Medical Net,Inc.

(3645)

Rating:62Neutral
Price Target:
¥336.00
▲(8.74%Upside)
The stock score reflects strong revenue growth and stable financial position but is offset by profitability challenges and a negative P/E ratio. Technical indicators suggest neutral to slightly positive trends, but valuation issues and cash flow management need improvement for long-term growth.

Medical Net,Inc. (3645) vs. iShares MSCI Japan ETF (EWJ)

Medical Net,Inc. Business Overview & Revenue Model

Company DescriptionMedical Net, Inc. (3645) is a healthcare-focused company operating within the medical services sector. The company specializes in providing a range of healthcare solutions, including telemedicine services, healthcare consulting, and medical data management. Medical Net, Inc. aims to leverage technology to enhance the accessibility and efficiency of healthcare delivery, providing innovative solutions to both healthcare providers and patients.
How the Company Makes MoneyMedical Net, Inc. generates revenue through a multi-faceted business model that includes subscription fees for its telemedicine platform, consultancy fees for healthcare advisory services, and licensing fees for its medical data management solutions. The company partners with healthcare institutions, insurance companies, and independent practitioners to deliver comprehensive healthcare solutions. Additionally, collaborations with technology firms help enhance their service offerings, contributing to revenue growth. Key revenue streams are primarily from its telemedicine services, which provide ongoing subscription-based income, as well as one-time consultancy projects and data management contracts.

Medical Net,Inc. Financial Statement Overview

Summary
Medical Net, Inc. shows strong revenue growth but is facing challenges in profitability and cash flow management. The balance sheet is stable; however, increasing leverage and declining ROE raise concerns. Despite operational cash generation, low net income and cash flow issues need addressing.
Income Statement
70
Positive
The company shows a solid revenue growth trajectory, with a 16.7% increase from 2023 to 2024. However, the net profit margin has significantly decreased due to a sharp decline in net income, affecting overall profitability. Despite this, the company maintains a reasonable gross profit margin, indicating efficient cost management. EBIT and EBITDA margins have suffered, suggesting operational challenges.
Balance Sheet
75
Positive
The balance sheet reflects a stable financial position with a high equity ratio of 47.8%, indicating strong financial stability. However, the debt-to-equity ratio has increased to 0.54 from the previous year, signaling a rise in leverage, which could pose future risks if not managed properly. The company's ROE has declined significantly, reflecting the drop in net income.
Cash Flow
65
Positive
The cash flow statement indicates a substantial decline in free cash flow, with a negative growth rate of -78.7%, primarily due to a reduction in operating cash flow. The operating cash flow to net income ratio remains positive, suggesting the company's ability to generate cash from operations, but the free cash flow to net income ratio has decreased, highlighting the need for improved cash management.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
5.82B5.25B4.50B3.75B2.90B2.92B
Gross Profit
1.95B1.84B1.78B1.46B1.18B972.40M
EBIT
173.96M298.28M379.65M445.12M331.27M106.38M
EBITDA
78.05M213.29M315.84M570.81M280.84M126.80M
Net Income Common Stockholders
-127.30M5.96M116.18M380.10M129.67M79.35M
Balance SheetCash, Cash Equivalents and Short-Term Investments
1.40B1.53B1.52B1.13B868.66M605.27M
Total Assets
3.57B3.99B3.47B3.15B2.11B1.74B
Total Debt
827.16M1.03B790.83M773.54M383.31M411.19M
Net Debt
-572.37M-498.82M-727.72M-360.45M-485.35M-194.09M
Total Liabilities
1.54B2.06B1.54B1.42B846.98M730.18M
Stockholders Equity
2.01B1.91B1.92B1.70B1.24B996.49M
Cash FlowFree Cash Flow
0.0086.79M408.50M340.39M378.84M69.56M
Operating Cash Flow
0.00119.59M429.13M342.55M391.87M78.29M
Investing Cash Flow
0.00-285.40M-62.37M-355.11M-87.99M-14.60M
Financing Cash Flow
0.00144.11M-17.90M282.23M-34.03M-497.40M

Medical Net,Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price309.00
Price Trends
50DMA
310.28
Negative
100DMA
312.99
Negative
200DMA
318.27
Negative
Market Momentum
MACD
-1.74
Positive
RSI
38.62
Neutral
STOCH
21.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3645, the sentiment is Negative. The current price of 309 is below the 20-day moving average (MA) of 317.17, below the 50-day MA of 310.28, and below the 200-day MA of 318.27, indicating a bearish trend. The MACD of -1.74 indicates Positive momentum. The RSI at 38.62 is Neutral, neither overbought nor oversold. The STOCH value of 21.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3645.

Medical Net,Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
¥3.72B3,633.15
14.51%84.03%
62
Neutral
¥2.70B
0.97%19.56%-906.44%
61
Neutral
$14.78B5.89-4.32%3.67%2.75%-30.30%
54
Neutral
¥2.11B
-22.04%-9.95%
51
Neutral
¥2.45B
-12.25%-142.67%
41
Neutral
¥1.73B
-29.86%-88.54%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3645
Medical Net,Inc.
306.00
-53.69
-14.93%
JP:2459
AUN Consulting, Inc.
231.00
22.00
10.53%
JP:3691
DIGITAL PLUS, Inc.
836.00
318.00
61.39%
JP:3845
I-Freek Mobile Inc.
99.00
8.00
8.79%
JP:3985
Temona, Inc.
228.00
13.00
6.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.